Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2018/035755, filed Jun 1, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,944,647 | Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | ||
| US 12,583,904 | Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | ||
| US 11,413,310 | Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | ||
| Application 18/510,460 | Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy Abandoned Abandoned Jan 11, 2025 | Juno Therapeutics, Inc. | Abandoned | Abandoned Jan 11, 2025 | not computed | |
| Application 19/383,220 | Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy Pending Not granted | Juno Therapeutics, Inc. | Pending | Not granted | not computed |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Juno, Inc..
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.